Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001736243-20-000001
Filing Date
2020-01-17
Accepted
2020-01-17 17:17:04
Documents
1
Effectiveness Date
2020-01-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11926
  Complete submission text file 0001736243-20-000001.txt   12945
Mailing Address 22 CAMELOT COURT WHITE PLAINS NY 10603
Business Address 22 CAMELOT COURT WHITE PLAINS NY 10603 914-949-3898
Acurx Pharmaceuticals, LLC (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-358483 | Film No.: 20534384